Mahendra Shah - Jun 16, 2022 Form 4 Insider Report for IMPEL PHARMACEUTICALS INC (IMPL)

Role
Director
Signature
/s/ John Leaman, M.D. as attorney-in-fact
Stock symbol
IMPL
Transactions as of
Jun 16, 2022
Transactions value $
$0
Form type
4
Date filed
6/17/2022, 05:05 PM
Previous filing
Jun 10, 2022
Next filing
Apr 28, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMPL Stock Option (right to buy) Award $0 +12.8K $0.00 12.8K Jun 16, 2022 Common Stock 12.8K $8.65 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option is 100% vested on June 16, 2023.